Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
HealthTech Innovation Days Expanding Reach with Virtual and In-Person Events with Maryvonne Hiance and Christian Policard HealthTech For Care TRANSCRIPT
Download PDFSep 30, 2020
Maryvonne Hiance, President, and Christian Policard, Board Member, HealthTech For Care talk about the upcoming HealthTech Innovation Days taking place virtually as well as in-person in Paris. Attendance is expected to dramatically increase over the participation at the first event held last year, in part driven by the...
Sep 30, 2020
Maryvonne Hiance, President, and Christian Policard, Board Member, HealthTech For Care talk about the upcoming HealthTech Innovation Days taking place virtually as well as in-person in Paris. Attendance is expected to dramatically increase over the participation at the first event held last year, in part driven by the...
Applying Advances in Cell Cycle Biology to Inhibit CDK2 and CDK9 to Overcome Resistance to Anti-Cancer Therapies with Spiro Rombotis Cyclacel Pharmaceuticals TRANSCRIPT
Download PDFSep 30, 2020
Spiro Rombotis, President and Chief Executive Officer, Cyclacel Pharmaceuticals dives into the insights about cell cycle check point control that have led to the development of fadraciclib, a potent orally and intravenously available inhibitor of CDK2 and CDK9 cancer pathways. Drawing on the vision of the company's...
Sep 30, 2020
Spiro Rombotis, President and Chief Executive Officer, Cyclacel Pharmaceuticals dives into the insights about cell cycle check point control that have led to the development of fadraciclib, a potent orally and intravenously available inhibitor of CDK2 and CDK9 cancer pathways. Drawing on the vision of the company's...
Refractory Angina Symptoms Significantly Improved by Medical Device with Fred Colen Neovasc TRANSCRIPT
Download PDFSep 23, 2020
Fred Colen, Chief Executive Officer, Neovasc sheds light on the four classes of angina and how the quality of life deteriorates for patients suffering from symptoms. Looking for the fundamental reason for the chronic condition of refractory angina has led Neovasc to address the small blood vessels inside the myocardium,...